{"id":"https://openalex.org/W2942013702","doi":null,"title":"Primjena monoklonskih protutijela u lije\u010denju malignih hematolo\u0161kih bolesti","display_name":"Primjena monoklonskih protutijela u lije\u010denju malignih hematolo\u0161kih bolesti","alternate_titles":[],"publication_year":2018,"publication_date":"2018-01-01","ids":{"openalex":"https://openalex.org/W2942013702","mag":"2942013702"},"language":"hr","primary_location":{"id":"mag:2942013702","doi":null,"is_oa":false,"landing_page_url":"https://dabar.srce.hr/en/islandora/object/pmf%3A4943","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null},"parent_works":[],"lineage":["https://openalex.org/W2942013702"],"child_works_count":0,"type":"dissertation","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5087949163","display_name":"Marija Lugar","orcid":"https://orcid.org/0009-0001-4339-0665","observed_orcids":["https://orcid.org/0009-0001-4339-0665"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Marija Lugar","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5087949163"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.92330002784729,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.92330002784729,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.047200001776218414,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.009600000455975533,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/monoclonal-antibodies","display_name":"monoclonal antibodies","score":1.0},{"id":"https://openalex.org/keywords/hematologic-malignancies","display_name":"hematologic malignancies","score":0.8659999966621399},{"id":"https://openalex.org/keywords/hybridoma-technology","display_name":"hybridoma technology","score":0.7919999957084656},{"id":"https://openalex.org/keywords/humanized-antibody","display_name":"humanized monoclonal antibody","score":0.7960000038146973},{"id":"https://openalex.org/keywords/chimeric-antibodies","display_name":"chimeric antibodies","score":0.9440000057220459},{"id":"https://openalex.org/keywords/antibody-humanization","display_name":"antibody humanization","score":0.6439999938011169},{"id":"https://openalex.org/keywords/tumor-associated-antigens","display_name":"tumor-associated antigens","score":0.7829999923706055},{"id":"https://openalex.org/keywords/rituximab","display_name":"rituximab","score":0.8090000152587891},{"id":"https://openalex.org/keywords/cd20","display_name":"CD20","score":0.828000009059906},{"id":"https://openalex.org/keywords/b-cell-malignancies","display_name":"B-cell malignancies","score":0.8119999766349792},{"id":"https://openalex.org/keywords/antibody-dependent-cellular-cytotoxicity","display_name":"antibody-dependent cellular cytotoxicity","score":0.8259999752044678},{"id":"https://openalex.org/keywords/complement-dependent-cytotoxicity","display_name":"complement-dependent cytotoxicity","score":0.9459999799728394},{"id":"https://openalex.org/keywords/apoptosis-induction","display_name":"apoptosis induction","score":0.7570000290870667},{"id":"https://openalex.org/keywords/immunotherapy","display_name":"immunotherapy","score":0.5989999771118164},{"id":"https://openalex.org/keywords/myeloid-neoplasms","display_name":"myeloid neoplasms","score":0.6729999780654907},{"id":"https://openalex.org/keywords/lymphoid-malignancies","display_name":"lymphoid malignancies","score":0.9950000047683716}],"concepts":[{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.7805261611938477},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.6901209354400635},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.5393296480178833},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.5212534070014954},{"id":"https://openalex.org/C195616568","wikidata":"https://www.wikidata.org/wiki/Q128711","display_name":"Epitope","level":3,"score":0.4851151704788208},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.47703713178634644},{"id":"https://openalex.org/C2778453870","wikidata":"https://www.wikidata.org/wiki/Q188930","display_name":"B cell","level":3,"score":0.4112780690193176},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.37790361046791077},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3596838712692261},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3497582674026489},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.18666094541549683}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:2942013702","doi":null,"is_oa":false,"landing_page_url":"https://dabar.srce.hr/en/islandora/object/pmf%3A4943","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W104559290","https://openalex.org/W2790230995","https://openalex.org/W2127472227","https://openalex.org/W2089939636","https://openalex.org/W2025931203","https://openalex.org/W2415136187","https://openalex.org/W7097925259","https://openalex.org/W2108121352","https://openalex.org/W2022640679","https://openalex.org/W2157963632"],"abstract_inverted_index":{"Monoclonal":[0,87],"antibodies":[1,3,32,88,216],"are":[2,74,89,144,153,165,224],"with":[4,38],"monovalent":[5],"affinity":[6],"(they":[7],"bind":[8],"to":[9,28,34,51,117,184,204],"the":[10,61,124,129,221],"same":[11],"epitope)":[12],"produced":[13],"by":[14,220],"clones":[15],"of":[16,22,60,79,94,98,112,133,137,150,156,171],"a":[17,77,90,145,172,185],"unique":[18],"parent":[19],"B-cell.":[20],"Discovery":[21],"hybridoma":[23],"technology":[24,47],"made":[25],"it":[26,48],"possible":[27,50],"produce":[29,52],"murine":[30],"monoclonal":[31,192,215],"specific":[33,161,178],"known":[35],"antigens":[36,122,157,162,179],"and":[37,44,55,67,85,100,110,123,176],"further":[39],"advances":[40],"in":[41,92,148,207,227],"genetic":[42],"engineering":[43],"recombinant":[45],"DNA":[46],"was":[49,194],"chimeric,":[53],"humanized":[54],"completely":[56],"human":[57],"antibodies.":[58],"Humanization":[59],"antibody":[62,193,198],"has":[63,202],"improved":[64],"its":[65,69],"efficacy":[66],"prolonged":[68],"half-life.":[70],"In":[71],"medicine":[72],"they":[73,126,143,158],"used":[75],"as":[76,107],"form":[78],"immunotherapy":[80],"for":[81,120],"autoimmune":[82],"diseases,":[83],"infections":[84],"tumors.":[86],"novelty":[91],"treatment":[93,149],"hematological":[95],"malignancies,":[96],"tumors":[97],"myeloid":[99],"lymphoid":[101],"cell":[102,174,187],"lineages,":[103],"alongside":[104],"common":[105],"therapies":[106],"chemotherapy,":[108],"radiotherapy":[109],"transplantation":[111],"hematopoietic":[113],"stem":[114],"cells.":[115],"Due":[116],"their":[118],"specificity":[119],"tumor-associated":[121],"effect":[125],"have":[127,217],"on":[128],"tumor":[130],"cells":[131],"(activation":[132],"ADCC,":[134],"CDC,":[135],"induction":[136],"apoptosis":[138],"or":[139,223],"blocking":[140],"ligand":[141],"binding),":[142],"great":[146],"option":[147],"malignancies.":[151,211],"There":[152],"two":[154],"types":[155],"recognize:":[159],"lineage":[160],"(LSA)":[163],"that":[164,181],"present":[166],"at":[167],"different":[168],"differentiation":[169],"steps":[170],"certain":[173],"lineage,":[175],"non-lineage":[177],"(NLSA)":[180],"aren\u2019t":[182],"restricted":[183],"single":[186],"lineage.":[188],"The":[189],"first":[190],"approved":[191,219],"rituximab,":[195],"an":[196],"anti-LSA":[197],"targeting":[199],"CD20,":[200],"which":[201],"shown":[203],"be":[205],"effective":[206],"treating":[208],"some":[209],"B-cell":[210],"Since":[212],"then,":[213],"many":[214],"been":[218],"FDA":[222],"being":[225],"tested":[226],"clinical":[228],"trials.":[229]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2942013702","counts_by_year":[],"updated_date":"2026-11-14T11:04:58.165337","created_date":"2019-05-03T00:00:00"}
